Shimamoto K, Chao J, Margolius H S
J Clin Endocrinol Metab. 1980 Oct;51(4):840-8. doi: 10.1210/jcem-51-4-840.
Human urinary kallikrein was purified to homogeneity, and an antiserum to it was raised in rabbits. A RIA was devised which uses this rabbit antiserum (Keq = 2.75 x 10(11) M-1) in a final dilution of 1:2,500,000 and the purified kallikrein labeled with 125I using a lactoperoxidase method. Assay sensitivity is 8 pg kallikrein. Thus far, the assay is specific for human and perhaps monkey urinary kallikrein. Correlations between this assay of immunoreactive kallikrein and the alpha-N-Tosyl-L-arginine-[3H]methylester (Tos-Arg-OMe) activity method or a kininogenase assay were highly significant (r = 0.94 and 0.96, respectively) and show that each assay measures human urinary kallikrein comparably. Low or high dietary sodium intakes, maneuvers known to change human urinary Tos-Arg-OMe esterase excretion, change immunoreactive kallikrein to an equivalent degree. Normal black children, already known to excrete significantly less Tos-Arg-OMe esterase than white children, excrete similarly reduced amounts of immunoreactive kallikrein. Kallikrein excretion in children with cystic fibrosis of the pancreas was not different from that in normal children. The data show that a specific and sensitive direct RIA for human urinary kallikrein has been developed and that both the Tos-Arg-OMe esterase and kininogenase assays measure human urinary kallikrein activity specifically, at least in the described circumstances.
人尿激肽释放酶被纯化至同质,并用其在兔体内制备了抗血清。设计了一种放射免疫分析方法,该方法使用最终稀释度为1:2,500,000的兔抗血清(平衡常数Keq = 2.75×10¹¹ M⁻¹)以及用乳过氧化物酶法标记有¹²⁵I的纯化激肽释放酶。检测灵敏度为8皮克激肽释放酶。到目前为止,该检测方法对人尿激肽释放酶具有特异性,可能对猴尿激肽释放酶也有特异性。这种免疫反应性激肽释放酶检测方法与α-N-对甲苯磺酰-L-精氨酸-[³H]甲酯(Tos-Arg-OMe)活性法或激肽原酶检测法之间的相关性非常显著(r分别为0.94和0.96),表明每种检测方法对人尿激肽释放酶的测量具有可比性。已知改变人尿Tos-Arg-OMe酯酶排泄的低或高膳食钠摄入量操作,会使免疫反应性激肽释放酶发生同等程度的改变。已知正常黑人儿童排泄的Tos-Arg-OMe酯酶明显少于白人儿童,其免疫反应性激肽释放酶的排泄量也同样减少。胰腺囊性纤维化患儿的激肽释放酶排泄量与正常儿童无异。数据表明,已开发出一种针对人尿激肽释放酶的特异性和灵敏的直接放射免疫分析方法,并且Tos-Arg-OMe酯酶和激肽原酶检测法至少在所述情况下能特异性地测量人尿激肽释放酶活性。